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Women who wish to undergo treatment for symptomatic relief from uterine
myomas while retaining the possibility of future pregnancies can currently choose
among several options, ranging from surgery to less invasive approaches.
1 As all
surgeries carry potential risks (operative, anesthetic, or infection) and possible
complications (uterine rupture and increased likelihood for a Caesarian delivery)
patients may opt for less invasive alternatives, which will also allow them to
return to their daily activities faster.
1,2
The most common treatment today for infertility due to myomas is myomec-
tomy. This procedure removes the myomas that distort the uterine cavity, thus
increasing pregnancy rates.
3 However, this is a major abdominal procedure, and
especially in the case of intramural myomas, the morbidity of the intervention
may outweigh the benefits of removing the myomas. In addition to surgical issues
such as infection and blood loss, removing myomas may also impair fertility by
inducing the formation of surgical adhesions.  
Uterine artery embolization has recently been offered as a treatment option for
women with myomas who have a desire for future fertility. However, this approach
is associated with an increased rate of caesarian delivery along with a relatively
higher percentage of complications (miscarriage, preterm delivery, intrauterine
growth restriction, abnormal placentation, malpresentation, and postpartum
hemorrhage),
4 suggesting that further study is required before the use of this
procedure becomes widespread in this patient population.  
Magnetic resonance imaging-guided focused ultrasound surgery (MRgFUS) is
currently used in our hospital for the treatment of symptomatic uterine myomas.
Case Report
DOI 10.3349/ymj.2010.51.3.451
pISSN: 0513-5796, eISSN: 1976-2437 Yonsei Med J 51(3): 451-453, 2010
Pregnancy and Natural Delivery Following 
Magnetic Resonance Imaging-Guided Focused
Ultrasound Surgery of Uterine Myomas
Sang-Wook Yoon,
1Kyoung Ah Kim,
1Sang Heum Kim,
1Doo Hoe Ha,
1Chan Lee,
2
Sun Young Lee,
2Sang-Geun Jung,
2and Seung-Jo Kim
2
Department of 1Diagnostic Radiology and 2Comprehensive Gynecologic Cancer Center, 
CHA Bundang Medical Center, CHA University, Seongnam, Korea.
This report discusses a pregnancy case following a series of two consecutive magnetic resonance imaging-guided
focused ultrasound surgery (MRgFUS) procedures for the treatment of two different myomas in an individual
patient. Both procedures were completed without adverse events, and the patient conceived naturally four months
after treatment. At 39 weeks, she gave birth to a healthy baby girl, via a vaginal delivery. There were no compli-
cations in the pregnancy or during labor.  
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This procedure is non-invasive, thus avoiding scar forma-
tion in the uterus. The treatment procedure incorporates a
3T MRI scanner (Signa HD, GE Healthcare, Milwaukee,
WI, USA) along with a focused ultrasound system (ExA-
blate 2000, Insightec, Haifa, Israel). The operator uses the
integrated system to deliver accurate energy pulses (termed
sonications) to a location identified on anatomical T2-
weighted MRI images. The heat generated during the course
of these sonications is monitored using images acquired in
real-time. At the end of the treatment, the results are eval-
uated by the non-perfused regions on T1-weighted contrast
enhanced images. These areas are summed to create a
volume, termed-non-perfused volume (NPV). The ratio of
the NPV to the volume of the myoma has been associated
with treatment effectiveness and myoma shrin-kage.
5,6 
MRgFUS is associated with a low complication rate,
and in some cases it may be suitable for women with myo-
mas who are seeking to retain their reproductive capabilities.
A number of successful cases have been published,
7-10
showing the feasibility of pregnancy following MRgFUS. 
This paper describes one patient who became pregnant
and gave birth following a series of two consecutive
MRgFUS treatments, treating two distinct uterine myomas.
A 31-year-old Korean woman [body mass index (BMI) of
19.7], without prior pregnancies, arrived at our clinic while
suffering from frequent urination and bulk symptoms. A
physical examination suggested that those symptoms
originated from the presence of uterine myomas. A pelvic
MRI exam, administered to determine the patient suita-
bility for an MRgFUS treatment, revealed two intramural
uterine myomas, whose combined volume was 201 cc
(divided between the smaller anterior one with 63 cc and
the larger posterior one with 138 cc). A review of the MR
images indicated that both myomas were suitable for
MRgFUS treatment. 
On the day of the MRgFUS treatment, bowels obstructed
the beam path to the posterior myoma and only the anterior
myoma was treated. Total treatment duration was 157
minutes, utilizing 67 focal spots (sonications) with a mean
energy of 1,260 Joules and a frequency of 1.15 MHz. The
patient was administered with conscious sedation (one
ample of Fentanyl) to alleviate pain and reduce motion.
Treatment was completed without complications and the
patient was discharged 30 minutes later.
One month later, the patient came for a second MRgFUS
treatment for the posterior myoma. To remove the obs-
truction resulting from the presence of bowels between the
transducer and the posterior myoma, the bladder was filled
using a Foley catheter with 150 cc of saline. In addition,
the rectum was filled with 100 cc of ultrasound gel to push
the uterus towards the anterior (Fig. 1). The treatment
utilized 121 sonications with a mean energy of 2,000 Joules.
The patient received conscious sedation (one ample of
Fentanyl), and she tolerated the treatment and the position
well. This treatment was also completed without compli-
cations and the patient left the hospital 30 minutes after it.
At the 3-month follow-up examination, the combined
volume of both myomas had shrunk by 13%, and large
Fig. 1. A typical sonication in the second treatment, whose target was the
dominant myoma.
Fig. 2.MR Images taken at the three-month follow-up visit. (A) T2-weighted axial
scan. (B) T1-weighted gadolinium-enhanced axial scan, with a significant
portion of the myoma still non-enhancing.
A
B
CASE REPORTPregnancy and Delivery Following MRgFUS of Uterine Myomas
Yonsei Med J   http://www.eymj.org    Volume 51   Number 3   May 2010 453
residual NPV was still apparent on the contrast-enhanced
T1-weighted images (Fig. 2).
Four months post treatment, the patient spontaneously
conceived, and she continued her pregnancy to term. After
39 weeks of normal pregnancy, a baby girl was born,
weighing 3,190 gram, through a vaginal delivery. No com-
plications were recorded during the labor or post-partum
periods. 
While patients with myomas may conceive and have natural
deliveries, several studies have suggested that the dimen-
sion and the location of myomas within the uterus may
interfere with a normal pregnancy.
1,2 Given the growing
tendency of women to postpone their pregnancies into
their late thirties,
11 there is a substantial and growing
interest in alternative treatments for symptomatic myomas
that are less invasive, offer minimized recovery times, and
retain childbearing potential.
We report here on a Korean patient whose two intramural
myomas were treated successfully with MRgFUS, and
who became pregnant four months later. We hypothesized
that by non-invasively ablating the inner portions of the
treated myomas, they would both shrink in size and would
become more flexible. The combination of these pheno-
mena may have contributed to reduction of the submucous
component of these intramural myomas and reduced the
possibility of uterine-cavity distortion. We do not know if
the treated patient had prior infertility issues, due to her
young age. Nevertheless, it is reassuring to see that no
safety events were associated with either the pregnancy
period or the delivery, following a course of two MRgFUS
treatments on two distinct myomas. 
There may be an important role for MRgFUS in women
with myomas who wish to become pregnant, by exploiting
the non-invasive nature of the treatment thereby avoiding
the operative risks. In addition, the real time monitoring of
the energy delivery would allow the operator to avoid poten-
tially sensitive areas. 
Large-scale clinical studies on women suffering from
myoma-related infertility are required to verify the safety
and the effectiveness of utilizing MRgFUS treatments for
enhancing fertility in patients with uterine myomas. 
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